Novel Medication as a Potential Smoking Cessation Aid
NCT02265367
·
clinicaltrials.gov ↗
NA
Phase
COMPLETED
Status
56
Enrollment
OTHER
Sponsor class
Conditions
Tobacco Use Disorder
Interventions
DRUG:
Levomilnacipran
DRUG:
Placebo
Sponsor
University of Minnesota